✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Halozyme Therapeutics Inc

Common Name
Halozyme Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
423
Ticker
HALO
Exchange
NASDAQ/NGS
Description
Halozyme Therapeutics Inc. is a biopharmaceutical company that researches, develops, and commercializes proprietary enzymes and drug delivery technologies. Its core platform centers on the patented re...

Halozyme Therapeutics's Board and Committee Meetings Data

Explore Halozyme Therapeutics's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
12a
Audit Committee Meeting Count
5a
Compensation/Remuneration Committee Meeting Count
6a
Nomination Committee Meeting Count
4a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Halozyme Therapeutics’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Halozyme Therapeutics's DEF 14A 2025